| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/15/2002 | CN1349411A Compositions containing benzimidazolones and progestogens |
| 05/15/2002 | CN1349410A Use of heparin-binding antagonists in the inhibition of bradykinin release |
| 05/15/2002 | CN1349409A Metabolic intervention with GLP-1 to improve the function of ischemic anc reperfused tissue |
| 05/15/2002 | CN1349408A Pegylated interferon alfa-CCR5 antagonist combination HIV therapy |
| 05/15/2002 | CN1349406A Combined preparations comprising morpholine anthracyclines and anticancer agent |
| 05/15/2002 | CN1348763A Medicine composite for preventing or treaitng diseases relating to IL-12 over growth |
| 05/15/2002 | CN1084743C 毒蕈碱拮抗剂 Muscarinic antagonist |
| 05/15/2002 | CN1084618C Use of serotonin antagonists (5HT3) for treatment disease |
| 05/15/2002 | CN1084595C Utilizations of edible oil |
| 05/15/2002 | CA2325074A1 Unknown |
| 05/14/2002 | US6387959 Adinistering a sulfur containing benzoic acid ester |
| 05/14/2002 | US6387950 4((4-chloro-3-hydroxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro -naphathalene-2-carbonyl)-amino)-2,6-difluoro-benzoic acid or its esters or salts used as agonists of alpha-retinoid receptors (=raralpha) |
| 05/14/2002 | US6387936 Combinations of riluzole and levodopa for the treatment of Parkinson's disease |
| 05/14/2002 | US6387935 Polycyclic dihydrothiazoles having substituted alkyl radicals in the two-position, process for their preparation, and their use as pharmaceuticals |
| 05/14/2002 | US6387916 Administering to humans, animals |
| 05/14/2002 | US6387913 Method of treating airway diseases with combined administration of A2B and A3 adenosine receptor antagonists |
| 05/14/2002 | US6387898 Treatment for CNS injuries |
| 05/14/2002 | US6387894 Use of CRF antagonists and renin-angiotensin system inhibitors |
| 05/14/2002 | US6387893 Adrenergic blocking agent; benign prosatatic hyperplasia |
| 05/14/2002 | US6387883 Method for the prevention and treatment of cachexia and anorexia |
| 05/14/2002 | US6387703 Selecting polynucleotide binding agent site and binding agent, contacting organism with site and agent, then detecting change in gene expression |
| 05/14/2002 | US6387673 Anticarcinogenic agent composed of ligand for steroid/thyroid hormone superfamily of receptors, histone deacetylase inhibitor which interacts with receptor, and pharmaceutically acceptable carrier |
| 05/14/2002 | US6387657 Amino acid sequence of wnt-1-induced secreted protein; anticarcinogenic agents; antitumor agents; treatment of arteriosclerosis; diagnosis of related disorders |
| 05/14/2002 | US6387629 Use of cathepsin S in the diagnosis and treatment of endometriosis |
| 05/14/2002 | US6387400 Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
| 05/14/2002 | US6387392 Comprising a pressure-sensitive adhesive layer containing a drug on a cloth which prevents the dilution of drug by saliva |
| 05/14/2002 | US6387390 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 05/14/2002 | US6387383 Topical low-viscosity gel composition |
| 05/14/2002 | US6387371 Specifically binds to an extracellular domain of the her2 receptor in an amount effective to inhibit growth of cancer cells |
| 05/14/2002 | US6387370 Reducing oxysterol buildup in the blood and normalizing cholesterol and blood pressure; phytochemicals with antioxidant properties found in fruits and vegetables, including polyphenols |
| 05/14/2002 | CA2267186C Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 05/14/2002 | CA2179540C Accelerated release composition containing bromocriptine |
| 05/14/2002 | CA2129287C Use of cloprostenol, fluprostenol and their analogues to treat glaucoma and ocular hypertension |
| 05/10/2002 | WO2002036829A2 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries |
| 05/10/2002 | WO2002036811A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 05/10/2002 | WO2002036771A2 Imaging, diagnosis and treatment of disease |
| 05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | WO2002036733A2 Cd36 as a heat shock protein receptor and uses thereof |
| 05/10/2002 | WO2002036634A2 Gene regulation therapy involving ferritin |
| 05/10/2002 | WO2002036611A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 05/10/2002 | WO2002036597A1 Tricyclic derivatives of indole with antiangiogenic activity |
| 05/10/2002 | WO2002036561A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 05/10/2002 | WO2002036203A2 Azole containing compositions with enhanced antifungal activity |
| 05/10/2002 | WO2002036202A2 Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid |
| 05/10/2002 | WO2002036171A1 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors |
| 05/10/2002 | WO2002036163A2 Novel medicament compositions consisting of tiotropium salts and antihistamines for treating respiratory illnesses |
| 05/10/2002 | WO2002036162A2 Compositions for treatment of ocular neovascularization and neural injury |
| 05/10/2002 | WO2002036152A1 Use of il-1 inhibitors and tnf antagonists, partially in combination with recombinant erythropoietins, for the treatment of anemia |
| 05/10/2002 | WO2002036149A2 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof |
| 05/10/2002 | WO2002036144A1 Gnrh analogues for treatment of urinary incontinence |
| 05/10/2002 | WO2002036135A2 Compositions for antitumour treatment containing ecteinascidin 743 |
| 05/10/2002 | WO2002036134A1 Pharmaceutical or dietary composition containing a vegetable oil, in particular olive oil, and sitosterol |
| 05/10/2002 | WO2002036133A1 New use |
| 05/10/2002 | WO2002036129A2 Topical treatment of mastalgia with arometese inhibitors such as androstendione |
| 05/10/2002 | WO2002036127A2 Methods and compositions for the treatment of polycystic ovary syndrome with chromium complexes |
| 05/10/2002 | WO2002036118A2 Heterocyclic derivatives useful as pharmaceutical agents |
| 05/10/2002 | WO2002036114A1 Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3 |
| 05/10/2002 | WO2002036108A2 Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases |
| 05/10/2002 | WO2002036107A2 Treatment of motor fluctuations with 5-hydroxytryptamine 1a receptor activity enhancing coumpounds |
| 05/10/2002 | WO2002036106A2 Novel medicament compositions based on anticholinergics and corticosteroids |
| 05/10/2002 | WO2002036105A2 Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders |
| 05/10/2002 | WO2002036103A1 Transdermal drug delivery system with improved water absorbability and adhesion properties |
| 05/10/2002 | WO2002036100A1 Controlled release metformin compositions |
| 05/10/2002 | WO2002036098A1 Method and preparation for binding acetaldehyde in saliva, stomach and large intestine |
| 05/10/2002 | WO2002036093A2 Anti-adiposis composition based on garlic bulb extracts |
| 05/10/2002 | WO2002036075A2 Small molecule compositions for binding to hsp90 |
| 05/10/2002 | WO2002036073A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same |
| 05/10/2002 | WO2002036072A2 Method for short-term and long-term drug dosimetry |
| 05/10/2002 | WO2002036071A2 Method of treating and preventing migraine headaches |
| 05/10/2002 | WO2002016381A3 Composition and method for inhibiting platelet aggregation |
| 05/10/2002 | WO2002011743B1 Treatment of prostate cancer |
| 05/10/2002 | WO2001097809A3 Method of treating cardiovascular disease using rapamycin |
| 05/10/2002 | WO2001093669A3 Compound screens relating to insulin deficiency or insulin resistance |
| 05/10/2002 | WO2001092337A3 Soluble ctla4 mutant molecules and uses thereof |
| 05/10/2002 | WO2001089564A3 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity |
| 05/10/2002 | WO2001085201A3 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 05/10/2002 | WO2001082919A3 Methods of and compounds for inhibiting calpains |
| 05/10/2002 | WO2001079469A3 Cloning of corynebacteriaceae histidine ammonia lyase and therapeutic uses |
| 05/10/2002 | WO2001079288A3 Cytokine uses; compositions; methods |
| 05/10/2002 | WO2001076570A3 Use of substances that act as cascade inhibitors of the raf/mek/erk signal cascade, for producing a medicament to treat dna and rna viruses |
| 05/10/2002 | WO2001074329A3 Sustained release beadlets containing stavudine |
| 05/10/2002 | WO2001070808A3 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 05/10/2002 | WO2001068697A3 Methods and compositions for immunoregulation |
| 05/10/2002 | WO2001068135A3 Compositions and methods for affecting osteogenesis |
| 05/10/2002 | WO2001068063A3 Novel use of (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts |
| 05/10/2002 | WO2001066742A3 G-protein coupled receptors |
| 05/10/2002 | WO2001066594A3 Human protein kinases and protein kinase-like enzymes |
| 05/10/2002 | WO2001064251A3 Combination chemotherapy |
| 05/10/2002 | WO2001064236A3 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS |
| 05/10/2002 | WO2001064214A3 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
| 05/10/2002 | WO2001062779A3 New transcription factor carp-2 |
| 05/10/2002 | WO2001051087A3 Novel treatment for eye disease |
| 05/10/2002 | WO2001046455A3 Survivin promotion of angiogenesis |
| 05/10/2002 | WO2001041780A3 Use of an immunosuppressant for increasing an antifugal activity of a lipopeptide |
| 05/10/2002 | WO2001039765A3 Compositions and methods for the induction and treatment of retinal detachments |
| 05/10/2002 | WO2001036487A3 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/10/2002 | WO2001036486A3 Scfv antibodies against disease associated molecules |
| 05/10/2002 | WO2001036467A3 Mammalian receptor proteins; related reagents and methods |
| 05/10/2002 | WO2001034157A9 Protease inhibitors |
| 05/10/2002 | WO2001034131A3 Combination chemotherapy |